Journal article
Anticardiolipin Antibodies Predict Early Recurrence of Thromboembolism and Death Among Patients with Venous Thromboembolism Following Anticoagulant Therapy
Abstract
PURPOSE: To compare the risk of recurrent venous thromboembolism in patients with and without antiphospholipid antibodies.
PATIENTS AND METHODS: Anticardiolipin antibodies were tested 6 months after a first or second episode of venous thromboembolism. Of the patients with a first episode of venous thromboembolism only the 412 who received 6 months of anticoagulation were studied. Two hundred and eleven patients with a second episode received …
Authors
Schulman S; Svenungsson E; Granqvist S; A. TDOASGTIAIPITDOASGALITA
Journal
The American Journal of Medicine, Vol. 104, No. 4, pp. 332–338
Publisher
Elsevier
Publication Date
April 1998
DOI
10.1016/s0002-9343(98)00060-6
ISSN
0002-9343